Reimagining GSK-3β Therapeutics in Alzheimer's Disease: From Inhibition to Activity Normalization and Targeted Degradation. - Manni E; Al-Kuraishy HM; Eisawy R; Abdelaziz AM; Batiha GE (Journal of molecular neuroscience : MN, 2026)